[Experiences with the effectiveness and tolerance of guanethidine/dipivefrin-AT in the treatment of increased intraocular pressure].
Investigation of the fixed combination of 0.5% guanethidine and 0.1% Dipivefrin demonstrated a good pressure-lowering effect (26.6% on average) as well as good subjective and objective tolerance. These findings justify its use as a preparation for lowering intraocular pressure.
D004359:Drug Therapy, Combination; D004837:Epinephrine / Q000009:adverse effects / Q000031:analogs & derivatives* / Q000627:therapeutic use; D005902:Glaucoma, Open-Angle / Q000188:drug therapy*; D006145:Guanethidine / Q000009:adverse effects / Q000627:therapeutic use*; D006801:Humans; D007429:Intraocular Pressure / Q000187:drug effects; D009798:Ocular Hypertension / Q000188:drug therapy*
C015173:dipivefrin; D004837:Epinephrine; D006145:Guanethidine
Erfahrungen über Wirksamkeit und Verträglichkeit von Guanethidin/Dipivefrin-AT bei der Behandlung des erhöhten Augeninnendruckes.